9 companies

Corcept Therapeutics

Market Cap: US$9.8b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

0I3Q

US$94.63

7D

4.2%

1Y

35.1%

Camurus

Market Cap: SEK 36.8b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

0RD1

SEK 622.50

7D

17.2%

1Y

-10.7%

Camurus

Market Cap: SEK 36.8b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

CAMXS

SEK 615.75

7D

16.6%

1Y

-12.0%

BioArctic

Market Cap: SEK 26.4b

Develops biological drugs for patients with central nervous system disorders in Sweden.

0RV2

SEK 303.50

7D

-3.1%

1Y

52.9%

BioArctic

Market Cap: SEK 26.4b

Develops biological drugs for patients with central nervous system disorders in Sweden.

BIOABS

SEK 297.40

7D

-9.5%

1Y

n/a

Bonesupport Holding

Market Cap: SEK 13.1b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

0RQO

SEK 203.00

7D

-12.7%

1Y

-35.1%

Bonesupport Holding

Market Cap: SEK 13.1b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEXS

SEK 219.70

7D

-5.5%

1Y

-30.6%

Kuros Biosciences

Market Cap: CHF 786.0m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

0RHR

CHF 19.92

7D

-3.9%

1Y

-27.8%

Kuros Biosciences

Market Cap: CHF 786.0m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

KURNz

CHF 19.93

7D

-4.1%

1Y

-27.7%